156 related articles for article (PubMed ID: 16629618)
1. Targeting Rho to stimulate repair after spinal cord injury.
McKerracher L; Higuchi H
J Neurotrauma; 2006; 23(3-4):309-17. PubMed ID: 16629618
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological approaches to repair the injured spinal cord.
Baptiste DC; Fehlings MG
J Neurotrauma; 2006; 23(3-4):318-34. PubMed ID: 16629619
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of intracellular Rho to stimulate axon growth and regeneration.
Ellezam B; Dubreuil C; Winton M; Loy L; Dergham P; Sellés-Navarro I; McKerracher L
Prog Brain Res; 2002; 137():371-80. PubMed ID: 12440379
[TBL] [Abstract][Full Text] [Related]
4. Rho-ROCK inhibition in the treatment of spinal cord injury.
Forgione N; Fehlings MG
World Neurosurg; 2014; 82(3-4):e535-9. PubMed ID: 23298675
[TBL] [Abstract][Full Text] [Related]
5. Rho signaling pathway targeted to promote spinal cord repair.
Dergham P; Ellezam B; Essagian C; Avedissian H; Lubell WD; McKerracher L
J Neurosci; 2002 Aug; 22(15):6570-7. PubMed ID: 12151536
[TBL] [Abstract][Full Text] [Related]
6. Molecular targets for therapeutic intervention after spinal cord injury.
Kwon BK; Borisoff JF; Tetzlaff W
Mol Interv; 2002 Jul; 2(4):244-58. PubMed ID: 14993395
[TBL] [Abstract][Full Text] [Related]
7. Mevalonate Cascade and Small Rho GTPase in Spinal Cord Injury.
Eftekharpour E; Nagakannan P; Iqbal MA; Chen QM
Curr Mol Pharmacol; 2017; 10(2):141-151. PubMed ID: 26758952
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the Rho-ROCK signaling pathway to promote neurologic recovery after spinal cord injuries in rats.
Wu BQ; Bi ZG; Qi Q
Chin Med J (Engl); 2013; 126(19):3723-7. PubMed ID: 24112171
[TBL] [Abstract][Full Text] [Related]
9. Rho as a target to promote repair: translation to clinical studies with cethrin.
McKerracher L; Guertin P
Curr Pharm Des; 2013; 19(24):4400-10. PubMed ID: 23360272
[TBL] [Abstract][Full Text] [Related]
10. Rho signaling and axon regeneration.
McKerracher L; Ferraro GB; Fournier AE
Int Rev Neurobiol; 2012; 105():117-40. PubMed ID: 23206598
[TBL] [Abstract][Full Text] [Related]
11. The promotion of neural regeneration in an extreme rat spinal cord injury model using a collagen scaffold containing a collagen binding neuroprotective protein and an EGFR neutralizing antibody.
Han Q; Jin W; Xiao Z; Ni H; Wang J; Kong J; Wu J; Liang W; Chen L; Zhao Y; Chen B; Dai J
Biomaterials; 2010 Dec; 31(35):9212-20. PubMed ID: 20869112
[TBL] [Abstract][Full Text] [Related]
12. Concise Review: Bridging the Gap: Novel Neuroregenerative and Neuroprotective Strategies in Spinal Cord Injury.
Ahuja CS; Fehlings M
Stem Cells Transl Med; 2016 Jul; 5(7):914-24. PubMed ID: 27130222
[TBL] [Abstract][Full Text] [Related]
13. Enhanced survival and regeneration of axotomized retinal neurons by repeated delivery of cell-permeable C3-like Rho antagonists.
Bertrand J; Di Polo A; McKerracher L
Neurobiol Dis; 2007 Jan; 25(1):65-72. PubMed ID: 17011202
[TBL] [Abstract][Full Text] [Related]
14. Local inhibition of Rho signaling by cell-permeable recombinant protein BA-210 prevents secondary damage and promotes functional recovery following acute spinal cord injury.
Lord-Fontaine S; Yang F; Diep Q; Dergham P; Munzer S; Tremblay P; McKerracher L
J Neurotrauma; 2008 Nov; 25(11):1309-22. PubMed ID: 19061375
[TBL] [Abstract][Full Text] [Related]
15. Spinal cord repair: strategies to promote axon regeneration.
McKerracher L
Neurobiol Dis; 2001 Feb; 8(1):11-8. PubMed ID: 11162236
[TBL] [Abstract][Full Text] [Related]
16. Rho Inhibitor VX-210 in Acute Traumatic Subaxial Cervical Spinal Cord Injury: Design of the SPinal Cord Injury Rho INhibition InvestiGation (SPRING) Clinical Trial.
Fehlings MG; Kim KD; Aarabi B; Rizzo M; Bond LM; McKerracher L; Vaccaro AR; Okonkwo DO
J Neurotrauma; 2018 May; 35(9):1049-1056. PubMed ID: 29316845
[TBL] [Abstract][Full Text] [Related]
17. Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system.
Dubreuil CI; Winton MJ; McKerracher L
J Cell Biol; 2003 Jul; 162(2):233-43. PubMed ID: 12860969
[TBL] [Abstract][Full Text] [Related]
18. NCAM-mediated locomotor recovery from spinal cord contusion injury involves neuroprotection, axon regeneration, and synaptogenesis.
Zhang S; Xia YY; Lim HC; Tang FR; Feng ZW
Neurochem Int; 2010 Jul; 56(8):919-29. PubMed ID: 20381564
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury.
Kitamura K; Iwanami A; Nakamura M; Yamane J; Watanabe K; Suzuki Y; Miyazawa D; Shibata S; Funakoshi H; Miyatake S; Coffin RS; Nakamura T; Toyama Y; Okano H
J Neurosci Res; 2007 Aug; 85(11):2332-42. PubMed ID: 17549731
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological approaches to induce neuroregeneration in spinal cord injury: an overview.
Ibarra A; Martiñón S
Curr Drug Discov Technol; 2009 Jun; 6(2):82-90. PubMed ID: 19519335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
